^
Association details:
Biomarker:No biomarker
Cancer:Uterine Corpus Leiomyosarcoma
Drug:pazopanib (Multi-tyrosine kinase inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
...other single agent options...can also be considered for advanced or metastatic disease, including dacarbazine...pazopanib...